Skip to main navigation Skip to search Skip to main content

Should somatostatin or gabexate be given for prophylaxis of pancreatitis in patients undergoing ERCP? Commentary

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish
Pages (from-to)14-15
Number of pages2
JournalNature Clinical Practice Gastroenterology and Hepatology
Volume5
Issue number1
DOIs
StatePublished - Jan 2008

Cite this